U.S. flag

An official website of the United States government

NM_144997.7(FLCN):c.250-2A>G AND not provided

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Jul 8, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000082633.19

Allele description [Variation Report for NM_144997.7(FLCN):c.250-2A>G]

NM_144997.7(FLCN):c.250-2A>G

Gene:
FLCN:folliculin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p11.2
Genomic location:
Preferred name:
NM_144997.7(FLCN):c.250-2A>G
HGVS:
  • NC_000017.11:g.17226324T>C
  • NG_008001.2:g.15865A>G
  • NM_001353229.2:c.250-2A>G
  • NM_001353230.2:c.250-2A>G
  • NM_001353231.2:c.250-2A>G
  • NM_144606.7:c.250-2A>G
  • NM_144997.7:c.250-2A>GMANE SELECT
  • LRG_325t1:c.250-2A>G
  • LRG_325:g.15865A>G
  • NC_000017.10:g.17129638T>C
  • NM_144997.5:c.250-2A>G
  • NM_144997.6:c.250-2A>G
Nucleotide change:
IVS4AS, A-G, -2
Links:
OMIM: 607273.0014; dbSNP: rs398124533
NCBI 1000 Genomes Browser:
rs398124533
Molecular consequence:
  • NM_001353229.2:c.250-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001353230.2:c.250-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001353231.2:c.250-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_144606.7:c.250-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_144997.7:c.250-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
Observations:
3

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000114675Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Aug 2, 2012)
germlineclinical testing

Citation Link,

SCV000321650GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Jan 31, 2023)
germlineclinical testing

Citation Link,

SCV004219715Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Pathogenic
(Jul 8, 2023)
unknownclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown3not providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic Risk Factors for Spontaneous Pneumothorax in Birt-Hogg-Dubé Syndrome.

Sattler EC, Syunyaeva Z, Mansmann U, Steinlein OK.

Chest. 2020 May;157(5):1199-1206. doi: 10.1016/j.chest.2019.12.019. Epub 2020 Jan 17.

PubMed [citation]
PMID:
31958439

A rare soft tissue tumor masquerading as a parathyroid adenoma in a patient with birt-hogg-dubé syndrome and multiple cervical endocrinopathies.

Mikesell KV, Kulaylat AN, Donaldson KJ, Saunders BD, Crist HS.

Case Rep Pathol. 2014;2014:753694. doi: 10.1155/2014/753694. Epub 2014 Dec 25.

PubMed [citation]
PMID:
25610687
PMCID:
PMC4290639
See all PubMed Citations (7)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000114675.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided3not providednot providednot provided

From GeneDx, SCV000321650.12

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown; Deletions involving coding exons of this gene are a known mechanism of disease (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19802896, 29357828, 18234728, 25610687, 21937013, 25525159, 31958439, 34654685)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV004219715.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The FLCN c.250-2A>G variant disrupts a canonical splice-acceptor site and interferes with normal FLCN mRNA splicing. This variant has been reported in the published literature in several affected individuals and families with Birt-Hogg-Dubé syndrome (PMIDs: 18234728 (2008), 31958439 (2020), and 35639097 (2022)). It has also been reported in early onset renal cell carcinoma (PMID: 34654685 (2021)) and rhabdomyoma (PMID: 25610687 (2014)). Based on the available information, this variant is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 5, 2025